Heart and kidney patients: is one pill a day better than two?
NCT ID NCT07259512
Summary
This study aims to find the best daily schedule for taking ramipril, a common medication for heart and kidney disease. Researchers will compare taking one larger dose per day versus two smaller doses in 80 patients who have both chronic kidney disease and a type of heart failure. The goal is to see which schedule better protects kidney function over 30 days by measuring specific markers in the blood and urine.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UNS Hospital
RECRUITINGKartasura, Central Java, Indonesia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.